FREQUENTLY ASKED QUESTIONS
Erebra® is effective in many diseases caused by viruses: influenza and its complications, parainfluenza, adenovirus infection, chickenpox, shingles, herpes infection (types I and II), cytomegalovirus infection, etc.
Erebra® is approved for use in children from 3 years of age, because at an earlier age, children do not know how to dissolve tablets. If the doctor prescribes Örebro for young children, then the tablet must be crushed and given to the child in powder form.
It is necessary to start taking Erebra® at the first symptoms of the disease.
Erebro® is an effective drug for the prevention of influenza and SARS, since it protects the mucous membrane of the upper respiratory tract - the main gateway for the virus.
In organized children's groups, the circulating respiratory pathogen changes almost every month. For this reason, many children get sick 6-10 times a year, making up a group of children with repeated episodes of ARVI.
Erebra® is an effective drug for the prevention of viral diseases, since it acts in a complex manner on all links of antiviral defense and immune response. In order to prevent viral diseases in the children's collective, the drug should be taken 2 times a day (in the morning, on the way to kindergarten and in the evening, on the way home) in doses according to age recommendations. Reception can last up to 3 weeks. If necessary, after a break of several weeks, the prophylaxis course can be repeated.
Erebra® is a herbal preparation, refers to low-toxic substances and does not cause changes in immune status.
Erebra® - the only drug in Ukraine, besides antiviral, immunomodulatory, and antioxidant action, has antibacterial and antifungal activity. This significantly (3 times) reduces the risk of secondary bacterial complications and in many cases avoids taking antibiotics.